Malaria vaccine decision-making framework

A tool to strengthen national decision-making around vaccine introduction

With a malaria vaccine moving closer to reality, MVI is ramping up efforts to help generate the data required for malaria-endemic countries to make timely and informed decisions about vaccine use.

MVI, the World Health Organization (WHO), and the health ministries of several African countries are working to develop a tool that will strengthen national decision-making processes and avoid the delays seen in introducing other life-saving interventions in the region.

Known as the Malaria Vaccine Decision-Making Framework (DMF), the tool is meant to promote preparation for a new vaccine at the national level.

MVI and WHO launched the DMF process in 2006 with support from the US Agency for International Development (USAID) and the Bill & Melinda Gates Foundation. MVI and WHO worked with countries to map data and processes according to when they would be needed in relation to the timeline for vaccine licensure.

The framework identifies such data needs as:

  • The malaria disease burden.
  • The likely impact of a future malaria vaccine.
  • The impact of current malaria interventions.
  • Financing options.

The process is helping countries, other partners, and MVI gain a better understanding of the kinds of information African health leaders consider essential to making decisions about malaria vaccine use.

Learn more: